Paragon Capital Management Inc Royalty Pharma PLC Transaction History
Paragon Capital Management Inc
- $136 Billion
- Q3 2024
A detailed history of Paragon Capital Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Paragon Capital Management Inc holds 16,402 shares of RPRX stock, worth $412,018. This represents 0.34% of its overall portfolio holdings.
Number of Shares
16,402
Previous 65,643
75.01%
Holding current value
$412,018
Previous $1.73 Billion
73.19%
% of portfolio
0.34%
Previous 1.32%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.03 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$944 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$578 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$405 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$304 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...